Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-06-25 @ 4:10 AM
Study NCT ID:
NCT00005869
Status:
UNKNOWN
Last Update Posted:
2013-12-04
First Post:
2000-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Sponsor:
Astex Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |